Swiss Chinese Life Science Forum 2021

On June 30, 2021, our Head of China Desk Lukas Zuest gave a presentation at the Swiss Chinese Life Sciences Forum 2021 about "China’s new 'dual circulation' strategy – How does it affect life science companies?".

He explained the...

China: The Future Belongs to Innovation

Speaker: Dr. Stefan Kohler Organiser: Swiss China Summit  Location: Rüschlikon

At the Swiss China Summit 2021, Stefan Kohler, Partner at VISCHER AG, moderated the panel with Dr. William Pao, Head of Pharmaceutical Research &...

Streitpunkt «Wirtschaftlichkeit» von Arzneimitteln

Woran krankt der therapeutische Quervergleich im Rahmen der dreijährlichen Überprüfung der SL-Aufnahmebedingungen? - in: Life Sciences Recht, LSR 2/2021, S. 81-87

Swiss digital health grows despite a lack of common jurisdiction

Kohler, Stefan, Swiss digital health grows despite a lack of common jurisdiction - An interview with Stefan Kohler, in:

From wearables sensors to collect physiological data to DNA’s sequences analysis with...

The Outlook for Chinese Healthcare

On September 25, 2019, VISCHER Manager of China Life Sciences Group Fiona Gao will give a presentation at the 19th Annual Biotech in Europe Forum. Her topic will be The Outlook for Chinese Healthcare: Changing Regulatory & Policy...

How to Structure Your Team

On September 19, 2019, VISCHER partner Dr. Matthias Staehelin will kick off the legal sessions of the BaseLaunch Healthcare Accelerator Program with his presentation on "How to Structure Your Team from a Legal Perspective"....

Besprechung der Dissertation von Leila Ghassemi Farreras

Kohler, Stefan, Besprechung der Dissertation von Leila Ghassemi Farreras "Utilisation of Traditional Medicinal Knowledge in the Industry – Legal Aspects and Protection in International Law", in: sic!, Schulthess Juristische Medien...

Lizenzgebühren im Pharmabereich: Arten, Strukturierung, Besonderheiten

LES Rigi-Seminar 2018Lizenzgebühren im Pharmabereich: Arten, Strukturierung, Besonderheiten

Highlights aus dem Inhalt

Arzneimittelentwicklung und Pharma License Deals

Kategorien von Vergütungen im Pharma-Lizenzvertrag Upfront...

Pricing & Reimbursement, Swiss perspective

BioLawEurope 2018, 4th Annual Meeting

Highlights aus dem Inhalt

Pharmaceutical market in Switzerland Pharmaceutical market by reimbursability Generics Sales outlets by turnover and inventory Biotech and gene tech products...

AIJA Double Winter Seminar: Sector specific M&A on the rise // Surviving after death – how to avoid nightmare estate

Moritz Jäggy, Life science M&A – asset deals, spin-offs, joint ventures, strategic alliances, and other collaborative arrangementsVeranstaltungsort: Valbella, Switzerland - Valbella Inn Reso

You are currently offline. Some pages or content may fail to load.